Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53

Cancer Letters

Volumn 233, Issue 2, 2006, Pages 315-327

  Deng, Win Ping ^a   Chao, Ming Wei ^a   Lai, Wen Fu ^a   Sun, Chi ^b   Chung, Chen Yen ^a   Wu, Cheng Chia ^a   Lin, I Hsin ^c   Hwang, Jeng Jong ^d   Wu, Chiu Hsiung ^e   Chiu, Wen Ta ^f   Chen, Chia Yu ^a   Redpath, John Leslie ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cancer reversion; HPV; IAP; p53; TCM; Yigan Kang

Indexed keywords

ALKALINE PHOSPHATASE; HERBACEOUS AGENT; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHINESE HERB; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; SKIN FIBROBLAST; TUMOR CELL; TUMOR GROWTH; ULTRAVIOLET C RADIATION; UTERINE CERVIX CANCER;

ALKALINE PHOSPHATASE; ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; HELA CELLS; HUMANS; INTESTINES; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED NOD; MICE, SCID; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 33644652336     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.03.031     Document Type: Article

References (29)

1. E.J. Stanbridge Suppression of malignancy in human cells Nature 260 1976 17 20
2. D. Brouty-boye, I. Gresser, and C. Baldwin Reversion of the transformed phenotype to the parental phenotype by subcultivation of X-ray-transformed C3H/10T1/2 cells at low cell density Int. J. Cancer 24 1979 253 260
3. V.A. Lavrovsky, M.A. Guvakova, and Y.V. Lavrovsky High frequency of tumour cell reversion to non-tumorigenic phenotype Eur. J. Cancer 28 1992 17 21
4. C. Sun, R.J. Antonionio, and J.L. Redpath Reversion of UVC-induced tumorigenic human hybrid cells to the non-tumorigenic phenotype Eur. J. Cancer 32A 1996 22 27
5. P.A. Kenny, and M.J. Bissell Tumor reversion: correction of malignant behavior by microenvironmental cues Int. J. Cancer 107 2003 688 695
6. F. Wang, V.M. Weaver, O.W. Petersen, C.A. Larabell, S. Dedhar, and P. Briand Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology Proc. Natl Acad. Sci. USA 25 1998 14821 14826
7. Taiwan: time to end the exile Lancet 354 1999 2093
8. H. Hu, N.S. Ahn, X. Yang, Y.S. Lee, and K.S. Kang Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell Int. J. Cancer 102 2002 250 253
9. M. McCulloch, M. Broffman, J. Gao, and J.M. Colford Jr Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials Am. J. Public Health 92 2002 1619 1628
10. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H.W. Doerr Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Lancet 361 2003 2045 2046
11. H.N. Zhang, J.H. He, L. Yuan, and Z.B. Lin In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage Life Sci. 73 2003 2307 2319
12. H. Yano, A. Mizoguchi, K. Fukuda, M. Haramaki, S. Ogasawara, S. Momosaki, and M. Kojiro The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase Cancer Res. 54 1994 448 454
13. S.H. Lin, I.C. Cheng, C.N. Weng, and C.M. Chen Effects of a Chinese herbal medicine Yigan Kang on TGEV infectivity in tissue culture J. Chin. Soc. Vet. Sci. 26 2000 110 116
14. D. Normile Asian medicine. The new face of traditional Chinese medicine Science 299 2003 188 190
15. C.J. Der, and E.J. Stanbridge A tumor-specific membrane phosphoprotein marker in human cell hybrids Cell 26 1981 429 438
16. K.M. Latham, and E.J. Stanbridge Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation Proc. Natl Acad. Sci. USA 87 1990 1263 1267
17. M.S. Mendonca, R.J. Antoniono, K.M. Latham, E.J. Stanbridge, and J.L. Redpath Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of gamma-irradiated HeLa x fibroblast cell hybrids Cancer Res. 51 1991 4455 4462
18. K.M. Latham, and E.J. Stanbridge Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa x fibroblast cell hybrids Cancer Res. 52 1992 616 622
19. H. Tsujimoto, S. Nishizuka, J.L. Redpath, and E.J. Stanbridge Differential gene expression in tumorigenic and non-tumorigenic HeLa x normal human fibroblast hybrid cells Mol. Carcinog. 26 1999 298 304
20. E.J. Stanbridge, R.R. Flandermeyer, D.W. Daniels, and W.A. Nelson-Rees Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids Somatic Cell Mol. Genet. 7 1981 699 712
21. E.J. Stanbridge, C.J. Der, C.J. Doersen, R.Y. Nishimi, D.M. Peehl, and B.E. Weissman Human cell hybrids: analysis of transformation and tumorigenicity Science 215 1982 252 259
22. M.S. Mendonca, K.L. Howard, D.L. Farrington, L.A. Desmond, T.M. Temples, and B.M. Mayhugh Delayed apoptotic responses associated with radiation-induced neoplastic transformation of human hybrid cells Cancer Res. 59 1999 3972 3979
23. M.S. Mendonca, L.A. Desmond, T.M. Temples, D.L. Farrington, and B.M. Mayhugh Loss of chromosome 14 increases the radiosensitivity of CGL1 human hybrid cells but lowers their susceptibility to radiation-induced neoplastic transformation Mutagenesis 15 2000 187 193
24. A.J. Terzis, F. Thorsen, O. Heese, T. Visted, R. Bjerkvig, and O. Dahl Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro Br. J. Cancer 75 1997 1744 1752
25. C.J. Li, C. Wang, and A.B. Pardee Induction of apoptosis by beta-lapachone in human prostate cancer cells Cancer Res. 55 1995 3712 3715
26. Y. Li, S.M. Rizvi, M. Ranson, and B.J. Allen 213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model Br. J. Cancer 86 2002 1197 1203
27. T.R. Evans, K.W. Colston, F.J. Lofts, D. Cunningham, D.A. Anthoney, and H. Gogas A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer Br. J. Cancer 86 2002 680 685
28. M. Du, X. Fan, E. Hong, and J.J. Chen Interaction of oncogenic papillomavirus E6 proteins with fibulin-1 Biochem. Biophys. Res. Commun. 296 2002 962 969
29. WAF1/CIP1 transcript is highly dependent on p53 for its basal expression in mouse tissues Oncogene 23 2004 8154 8157